Qube Research & Technologies (QRT)’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-125,506	Closed	-$4.64M	–	3407
2024 Q2	$4.64M	Sell	125,506 -80,658	-39%	-$3.04M	0.01%	1291
2024 Q1	$8.65M	Buy	206,164 +161,196	+358%	+$6.62M	0.01%	925
2023 Q4	$1.78M	Buy	44,968 +40,669	+946%	+$1.2M	﹤0.01%	1581
2023 Q3	$118K	Sell	4,299 -64,548	-94%	-$2.02M	﹤0.01%	2609
2023 Q2	$2.34M	Buy	68,847 +6,902	+11%	+$233K	0.01%	987
2023 Q1	$2.23M	Buy	61,945 +28,271	+84%	+$1.22M	0.01%	957
2022 Q4	$1.5M	Buy	33,674 +26,198	+350%	+$935K	0.01%	1049
2022 Q3	$210K	Buy	+7,476	New	+$229K	﹤0.01%	1759
2021 Q2	–	Sell	-64,913	Closed	-$1.34M	–	2320
2021 Q1	$1.34M	Sell	64,913 -106,405	-62%	-$2.44M	0.02%	735
2020 Q4	$3M	Buy	171,318 +97,734	+133%	+$1.76M	0.04%	464
2020 Q3	$1.09M	Buy	73,584 +37,250	+103%	+$436K	0.02%	790
2020 Q2	$472K	Buy	+36,334	New	+$161K	0.01%	1140